Market & Financials

Market opportunity, competitive landscape, and financial projections.

Market Opportunity

Target Market Size

Our target market includes blind and visually impaired individuals across the UK, with plans to expand to EU and USA markets.

0
Blind or Partially Sighted in UK
0
Blind or Partially Sighted in Europe
0
Blind or Partially Sighted in USA
0
Low Vision People in UK
0
Low Vision People in Europe
0
Low Vision People in USA

Market Growth & Trends

The global assistive technology market for visually impaired is experiencing significant growth:

  • Market Size: £14.2 billion in 2023
  • CAGR: 8.5% from 2024 to 2030
  • Projected Size: £23.7 billion by 2030
Key Market Drivers:
  • Aging Population: Growing elderly demographic with age-related vision impairments
  • Technology Advancement: AI and computer vision innovations enabling new capabilities
  • Increasing Acceptance: Growing adoption of wearable assistive technology
  • Policy Support: Government initiatives promoting accessibility technology
  • Remote Support: Rising demand for telehealth and remote assistance capabilities

Competitive Advantage

Competitor Product Comparison

Feature Mavis Competitor A Competitor B
Navigation and Obstacle Detection
Text to Speech
Object Recognition and Description
Emergency Audio/Video Call
Custom Made Applications/Modules
Surface Analysis and measurements
Own Software
Own Hardware
Price (£) 650 2,000+ 1,800+

Key Differentiators

  • Price Point: Our smart glasses are 2-3x more affordable than competitors
  • Vertical Integration: Complete in-house control over hardware, software, and design
  • Manufacturing Facility: Our own UK-based manufacturing reduces costs and improves quality control
  • Support Model: 24/7 one-way video support subscription offers unique assistance
  • Customization: Modular approach allows for personalized solutions

Comparison to Traditional Solutions

Smart Glasses vs. Guide Dogs:
  • Cost Efficiency: £650 one-time cost vs. £50,000+ to train a guide dog
  • Availability: Immediate purchase vs. 1+ year waiting list for guide dogs
  • Functionality: Multiple assistance features vs. primarily navigation support
  • Independence: Works for individuals of all ages including children
  • Maintenance: No daily care requirements or retirement concerns

In 2022 alone, £148 million was allocated for training guide dogs in the UK, while the government spends £25 billion annually on care for visually impaired individuals.

Financial Data

Revenue & Profit Projections

Financial Summary

Mavis Technologies shows strong financial trajectory with revenue growing from €125K to £9.67M in five years.

Financial Metric 2025 2026 2027 2028 2029 2030
Total Revenue (£) 125k 1,167k 1,773k 2,994k 6,234k 9,672k
One-off / Subscription (%) 90 / 10 78 / 22 58 / 42 42 / 58 35 / 65 17 / 83
EBITDA (£) -265k -47k 99k 566k 1,552k 3,337k
EBITDA % -212% 4% 6% 19% 25% 35%
Units Sold 200 1,300 1,800 3,000 8,000 14,000
Products on Market 1 1 2 2 3 3
Countries Sold In 1 1 1 1 1 1
TAM / Market Penetration 150k / 0.1% 150k / 1.0% 1M / 0.3% 1M / 0.6% 2M / 0.7% 2M / 1.4%

Investment Overview

Total Ask: £350,000

14% Raised

£50,000 of £350,000 raised so far

Funding Distribution
  • Marketing & Launch
    40% – Launch campaign and secure 1,000 users
    40%
  • Product Development
    30% – Complete CE testing and software iteration
    30%
  • Operations & Support
    20% – Set up user support and training
    20%
  • Contingency
    10% – Maintain a 12–15 month runway
    10%

Business Model

Revenue Streams
  • Direct Product Sales: £650-£725 per unit
  • Support Service Subscription: £30 per month, including 24/7 one-way video call support
Sales Strategy
  • Direct-to-Consumer: Online sales through e-commerce platform
  • B2B Approaches: Relationships with blind communities and rehabilitation centers
  • B2B2C: Partnerships with distributors and sales partners
  • Healthcare Providers: Recommendations from ophthalmologists and optometrists

Cost Structure

  • Manufacturing: Component costs, assembly, and quality control
  • R&D: Continuous product improvement and new product development
  • Operations: Facility costs, utilities, and administrative expenses
  • Marketing and Sales: Digital marketing, trade shows, and partner support
  • Customer Support: Support service center operation and training

Our vertical integration approach and manufacturing efficiency help maintain lower production costs compared to competitors, enabling us to offer premium products at more accessible price points.

Growth Strategy

  • Market Expansion: Starting with UK market, then expanding to EU and USA
  • Product Line Expansion: Following our product roadmap to address diverse needs
  • Partnership Development: Strategic partnerships with healthcare providers and rehabilitation centers
  • Subscription Services: Growing the recurring revenue through support services
  • Innovation Leadership: Continuous investment in R&D to maintain competitive advantage

We project reaching profitability in 2026, with significant growth in both revenue and profit margins in subsequent years.

Exit Strategy

Our planned exit strategy includes several potential avenues that provide significant returns to our investors:

Strategic Acquisition

Acquisition by a larger healthcare technology company, medical device manufacturer, or assistive technology provider looking to expand their portfolio in the growing assistive technology market.

Estimated timeline: 5-7 years

Private Equity Sale

Sale to private equity firms interested in the healthcare technology sector, particularly those with portfolios in assistive devices, healthcare innovation, or accessibility solutions.

Estimated timeline: 4-6 years

IPO

If growth trajectories continue as projected, pursuing an Initial Public Offering to access public markets, increase capital, and provide liquidity to early investors.

Estimated timeline: 7-10 years